Noticias de Eulerpool Beam Therapeutics

Beam Therapeutics Noticias de Acciones

Beam Therapeutics es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Beam Therapeutics.

• 17 de junio ·

  Yahoo
  Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover
• 13 de junio ·

  Yahoo
  Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 Supporting Differentiated Profile in Sickle Cell Disease (SCD) at European Hematology Association (EHA) 2025 Congress
• 5 de junio ·

  Yahoo
  Beam Therapeutics (BEAM) Up 5.7% Since Last Earnings Report: Can It Continue?
• 4 de junio ·

  Yahoo
  BEAM Up on FDA's Orphan Drug Status for Gene-Editing Therapy
• 3 de junio ·

  Yahoo
  Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-101 for the Treatment of Sickle Cell Disease
• 30 de mayo ·

  Yahoo
  FDA Grants Orphan Drug Status to Beam Therapeutics Inc. (BEAM)’ AATD Gene Therapy
• 29 de mayo ·

  SeekingAlpha
  Beam Therapeutics: A Cautious Hold On A Base Editing Pioneer
• 13 de mayo ·

  Yahoo
  Beam Therapeutics to Participate in 2025 RBC Capital Markets Global Healthcare Conference
• 9 de mayo ·

  Yahoo
  Is Beam Therapeutics (NASDAQ:BEAM) In A Good Position To Invest In Growth?
• 7 de mayo ·

  Yahoo
  BEAM Stock Down 19% as Q1 Earnings & Revenues Miss Estimates